OSD
OSD
New trends and technologies are constantly reshaping how we develop and manufacture life-saving drugs. Staying ahead of the curve requires a keen understanding of these emerging trends and their potential implications for the industry.
In recent commentaries, Dr. Uwe Hanenberg, PhD, Head of Product Implementation at Recipharm, identified several key trends that are poised to significantly influence drug development in 2025, including:
As the demand for patient-centric solutions, specialised capabilities, and integrated services grows, staying ahead of these trends will be essential for success in 2025. By proactively investing in the necessary technologies and expertise, CDMOs can effectively support their clients in navigating this evolving landscape and delivering safe, effective and patient-centric therapies to market.
Learn more about these trends and their implications for drug development in our recent commentaries: